ORTHOGEN AG | About us

Orthogen AG and its Members

The biotech research company was founded in 1993 and employs around 20 people with various scientific qualifications and experiences. Orthogen AG is a privately held Holdings Company located in Dusseldorf, Germany where its founder and CEO,
Prof. (USA) Dr. Peter Wehling and his management team reside.

Part of our core competency is creating molecular/biological insights, patenting those discoveries and technologies and bringing these to patients in need.

Management Team

Peter Wehling, MD, PhD

CEO and Founder of Orthogen AG

Pioneer in the field of Regenerative Medicine and Molecular Orthopedics
Specialist in orthopedics and sports medicine with focus on the treatment of chronic pain and care of top athletes
Member of the medical faculty at Heinrich-Heine-University Düsseldorf, Germany, and Professor adj. at Duke University, NC, USA

Julio Reinecke, PhD

CSO and Co-Founder of Orthogen AG

established laboratory and production infrastructure as well as biotechnology methods
Research focus on autologous biologic treatments and local inflammatory conditions such as Osteoarthritis

Christopher Evans, PhD

Chairman of the Supervisory Board

Professor of Orthopedic Surgery Emeritus at Harvard Medical School
Director of the Rehabilitation Medicine Research Center at the Mayo Clinic
Research focus on treatment of arthritis

Simone_Sandku%C3%8C%C2%88hler_72dpi_kpmg

Simone Sandkühler, PhD

Member of the Supervisory Board

Senior manager at KPMG Advisory in Management Consulting
Former management consultant at Boston Consulting Group
PhD in Neuroscience, University of Vienna

Gary Tobey

Member of the Supervisory Board

CEO and Chairman of Haworth Marketing + Media
developed top level executive relationships in the Media, Entertainment and Sports industries

Michael Hamilton

Consultant Strategy Projects for Orthogen AG

Managing Director of Triangle BioVentures
Former VP, global commercial strategy (infectious diseases) and former VP, global product strategy (neuroscience) at GlaxoSmithKline
Former CEO of ALG Therapeutics

Klaus Wehling

Legal Consultant for Orthogen AG

Co-Founder of Orthogen AG
CFO of Orthogen AG for 20 years (until the end of 2020)
Consultant for legal and commercial matters

In Honor

William Maixner, DDS, PhD

Former Member of the Supervisory Board
deceased on Nov 2nd, 2020

Former President of the American Pain Society
Director Innovative Pain Therapies at Duke University
Co-Director of the Center for Translational Pain Medicine (CTPM) at Duke University